284
Views
17
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Disease progression and survival in ALS: First multi‐state model approach

, , , , , & show all
Pages 224-229 | Received 15 Nov 2006, Accepted 10 Feb 2007, Published online: 10 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Nimish J. Thakore, Brittany R. Lapin, Tyler G. Kinzy & Erik P. Pioro. (2018) Deconstructing progression of amyotrophic lateral sclerosis in stages: a Markov modeling approach. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 483-494.
Read now
Susana Pinto & Mamede de Carvalho. (2017) Comparison of slow and forced vital capacities on ability to predict survival in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 528-533.
Read now
Juan Gil, Maria C. Vazquez, Carlos Ketzoian, Abayuba Perna, Benoit Marin, Pierre Marie Preux & Philippe Couratier. (2009) Prognosis of ALS: Comparing data from the Limousin referral centre, France, and a Uruguayan population. Amyotrophic Lateral Sclerosis 10:5-6, pages 355-360.
Read now
Benoit Marin, Juan Gil, Pierre Marie Preux, Benoit Funalot & Philippe Couratier. (2009) Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997–2007. Amyotrophic Lateral Sclerosis 10:4, pages 216-220.
Read now
Henrik Ryberg & Robert Bowser. (2008) Protein biomarkers for amyotrophic lateral sclerosis. Expert Review of Proteomics 5:2, pages 249-262.
Read now

Articles from other publishers (12)

Robert P. Finger, Marie-Therese Puth, Matthias Schmid, Daniel Barthelmes, Robyn H. Guymer & Mark Gillies. (2020) Lifetime Outcomes of Anti–Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration. JAMA Ophthalmology 138:12, pages 1234.
Crossref
Vanessa X. Tan & Gilles J. Guillemin. (2019) Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis. Frontiers in Neuroscience 13.
Crossref
Susana Pinto & Mamede de Carvalho. (2019) SVC Is a Marker of Respiratory Decline Function, Similar to FVC, in Patients With ALS. Frontiers in Neurology 10.
Crossref
Rup Tandan, Waqar Waheed & Connor Scagnelli. 2019. Handbook of Famine, Starvation, and Nutrient Deprivation. Handbook of Famine, Starvation, and Nutrient Deprivation 981 1033 .
Rup Tandan, Waqar Waheed & Connor Scagnelli. 2019. Handbook of Famine, Starvation, and Nutrient Deprivation. Handbook of Famine, Starvation, and Nutrient Deprivation 1 53 .
Sabrina K. Hollinger, Ike S. Okosun & Cassie S. Mitchell. (2016) Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?. Frontiers in Neurology 7.
Crossref
Alexandru Dan CorlanJohn Ross. (2015) Kinetics methods for clinical epidemiology problems. Proceedings of the National Academy of Sciences 112:46, pages 14150-14155.
Crossref
J. D. Beard & F. Kamel. (2014) Military Service, Deployments, and Exposures in Relation to Amyotrophic Lateral Sclerosis Etiology and Survival. Epidemiologic Reviews 37:1, pages 55-70.
Crossref
Philippe Couratier, Benoît Marin, Géraldine Lautrette, Marie Nicol & Pierre-Marie Preux. (2014) Épidémiologie, spectre clinique de la SLA et diagnostics différentiels. La Presse Médicale 43:5, pages 538-548.
Crossref
M. ElaminJ. PhukanP. BedeN. JordanS. ByrneN. PenderO. Hardiman. (2011) Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 76:14, pages 1263-1269.
Crossref
M.-H. Soriani & C. Desnuelle. (2009) Épidémiologie de la SLA. Revue Neurologique 165:8-9, pages 627-640.
Crossref
L. V. Brylev, E. N. Nelkina, A. A. Yakovlev, M. V. Onufriev, A. A. Shabalina, M. V. Kostyreva, M. N. Zakharova, I. A. Zavalishin & N. V. Gulyaeva. (2009) Modulators of cystein proteases and cell-death markers in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Neurochemical Journal 3:2, pages 133-138.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.